论文信息 - Second‐line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild‐type KRAS - 字舞流文

Second‐line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild‐type KRAS

Jong Hoon Kim | Jae-Lyun Lee | J. Baek | S. Park | Y. Hong | Seok-Byung Lim | Kyu-pyo Kim | C. Yu | Hwa Jung Kim | Jin-hong Park | Sun Young Kim | J. C. Kim | T. W. Kim | Y. Hong